SecBot SecBot
8-K ·Filed Nov 5, 2026

MYGN

MYRIAD GENETICS INC
NEUTRAL
Impact 4/10
Horizonweeks Processed11d 15h ago SEC0001628280-26-070659
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor subsequent filings for updates on the investigation's findings, any regulatory inquiries (HIPAA, FTC), and potential remediation costs or legal liabilities if patient data was compromised.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$6.29
T+0 close · Nov 5, 2026 · via day close
Latest settled
−9.70%
T+5 · $5.68
Vs SPY
−12.99%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $6.29entry
  2. T+1 · 11d ago −5.88%α −6.19% · $5.92
  3. T+5 · 5d ago −9.70%α −12.99% · $5.68
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Myriad Genetics disclosed a cybersecurity incident on November 2, 2026, involving unauthorized access to its IT network. The company temporarily suspended testing operations and order management systems, and most systems have since returned to normal. Management does not believe the incident will have a material adverse effect on its business, but the investigation into the scope, including potential patient record access, is ongoing.

Key Facts

  • Unauthorized access detected on November 2, 2026
  • Testing operations and order management systems temporarily suspended
  • Most systems have returned to normal operations
  • External experts engaged to assist investigation
  • Full scope of unauthorized access remains under investigation, including potential patient record access
  • Company does not believe the incident will have a material adverse effect on its business

Financial Impact

No financial impact quantified in the filing; company states belief that incident will not have a material adverse effect

Risk Factors

  • Potential regulatory penalties or litigation if patient records were accessed
  • Reputational damage and loss of customer trust
  • Possible future costs for remediation, credit monitoring, or legal defense
  • Investigation is ongoing and scope of impact is not yet fully known

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
7% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-070659
Document: 0001628280-26-070659-index-headers.html0001628280-26-070659
Document: 0001628280-26-070659-index.html0001628280-26-070659
Document: 0001628280-26-070659.txt0001628280-26-070659

Track record

16 reports on MYGN

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.54% at T+5 after the Oct 20, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $5.57 Now $5.57 −0.00% settles Nov 18
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $5.67 to $5.72 Now $5.57 −1.76% ▲ +0.88% −0.44% vs SPY
  3. Nov 5, 202611d ago 8-K Neutral 4/10 Viewing Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
  4. Nov 4, 202612d ago 8-K Mixed 6/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
  5. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $6.02 to $6.29 Now $5.57 −7.48% ▲ +4.49% +8.89% vs SPY
  6. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $6.63 to $6.67 Now $5.57 −15.99% ▲ +0.60% +0.99% vs SPY
  7. Oct 20, 202627d ago 8-K Bullish 7/10 Entry $5.54 to $5.57 Now $5.57 +0.54% ▲ +0.54% +0.02% vs SPY
  8. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $3.98 Now $5.57 +39.95% No price data
  9. Oct 9, 20265w ago 8-K Neutral 3/10 Entry $4.20 to $4.08 Now $5.57 +32.62% ▼ −2.86% −2.85% vs SPY
  10. Sep 16, 20268w ago 8-K Neutral 3/10 Entry $3.86 to $4.14 Now $5.57 +44.30% ▲ +7.25% +6.12% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 8h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026